With the analysis among 11,917 patents, we discovered top 495 key players by total patent application. Novartis AG, AstraZeneca Pharmaceutical Co., Ltd., Sandoz AG are dominant in this area. They take 13.25% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 702
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 495
New York, United States
Patent: 253
Hovedstaden, Denmark
Patent: 203
F. Hoffmann-La Roche Ltd.
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 159
Nordrhein-Westfalen, Germany
Patent: 136
Nordrhein-Westfalen, Germany
Patent: 135
With the analysis among 82 patents, we discovered top 21 start-ups by total patent application. SyntheX, Inc., Secura Bio, Inc., Shenzhen Tajirui Biomedical Co. Ltd. are active in this area.
California, United States
Patent: 23
Nevada, United States
Patent: 7
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 6
Censa Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 6
California, United States
Patent: 5
Institut National de la Santé et de la Recherche Médicale
Texas, United States
Patent: 3
Maharashtra, India
Patent: 3
Kinoxis Therapeutics Pty Ltd.
Victoria, Australia
Patent: 3
With the analysis among related 1,063 patents applied in the last 5 years. We discover 312 most active companies in this area. The fast-growing Amicus Therapeutics, Inc., Pfizer Inc., Sanovel Ilaç Sanayi ve Ticaret AS take 13.73% of patent filing during this period.
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 64
New York, United States
Patent: 52
Sanovel Ilaç Sanayi ve Ticaret AS
California, United States
Patent: 28
California, United States
Patent: 28
California, United States
Patent: 25
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 24
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 24
New Jersey, United States
Patent: 22
Aldeyra Therapeutics, Inc.
Massachusetts, United States
Patent: 18
With the analysis among related 1,063 patents in last 5 years, we discover 190 new entrants. Amgen, Inc., Cytokinetics, Inc., Aldeyra Therapeutics, Inc. are the most active new entrants in this area.
California, United States
Patent: 28
California, United States
Patent: 25
Aldeyra Therapeutics, Inc.
Massachusetts, United States
Patent: 18
Shanghai Bocimed Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 13
California, United States
Patent: 13
Blueprint Medicines Corp.
Massachusetts, United States
Patent: 9
Massachusetts, United States
Patent: 9
Adeptio Pharmaceuticals Ltd.
With the analysis among 373 patents, we discovered top 58 universities and scientific research institutions by total patent application. Shanghai Institute of Pharmaceutical Industry, The Trustees of Columbia University in The City of New York, University of Vermont are dominant in this area. They take 23.86% of the total patent filing.
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 45
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 22
Massachusetts, United States
Patent: 22
Tianjin Shi, China
Patent: 11
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 9
Council of Scientific & Industrial Research
Loyola University of Chicago
Illinois, United States
Patent: 7
Zhejiang Sheng, China
Patent: 7
North Carolina State University
North Carolina, United States
Patent: 3
The Robert Gordon University
Aberdeen City, United Kingdom
Patent: 3